Laboratory diagnosis and control of diabetes mellitus;Laboratorní diagnostika a sledování stavu diabetes mellitus

Diabetologie Metabolismus Endokrinologie Vyziva

Volumn 7, Issue 1, 2004, Pages 46-54

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C;

ARTICLE; DATA ANALYSIS; DIABETES MELLITUS; DIET RESTRICTION; HUMAN; LABORATORY DIAGNOSIS; ORAL GLUCOSE TOLERANCE TEST; RISK ASSESSMENT; SCREENING TEST; SEROLOGY; SYMPTOM; WORLD HEALTH ORGANIZATION;

EID: 1842767352     PISSN: 12119326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Definition, Diagnosis and Classification of Diabetes mellitus and Its Complications. World Health Organisation 1999, WHO/NCD/NCS/99.2.
2. American Diabetes Association. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 25, Supplement 1, January 2002: S5-S20.
3. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK a spol. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Clin Chem 2002; 48: 436-472.
4. American Diabetes Assotiation. Clinical Practice Recommendations. Diabetes Care 2003; 26, Suppl 1, S1-S20.
5. Reinauer H, Home PD, Kanabasagapathy AS, Heuck C-Ch. Laboratory diagnosis and monitoring of diabetes mellitus. World Health Organization 2002.
6. Stahl M, Joergensen GM, Hyltoft Petersen P. Optimization of preanalytical conditions and analysis of plasma glucose. Scand J Clin Lab Invest 2001; 61;169-180.
7. Burnett RW, D'Orazio P, Fogh-Andersen A, Kuwa K, Kulpmann WR,a spol. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001; 307: 205-209.
8. Fraser CG. Biological variation: From principles to practice.AACC Press 2001.
9. Jorgensen GM, Stahl M, Brandslund I, Hyltoft Petersen P, Borch--Johnsen K, De Fine Olivarius N. Plasma glucose reference interval in a low risk population. 2. Impact of the new WHO and ADA recommendations on the diagnosis of diabetes mellitus. Scand J Clin Lab Invest 2001; 61; 181-190.
10. prISO 15189.2 Quality management in the medical laboratory. ISO. Geneva 2002.
11. NGSP Steering Committee.Implementation of the national glycohemoglobin standardization program.Diabetes 1997; 46: 151A.
12. Little RR, Rohlfing CL, Wiedemayer HM, Myers GL, Sacks DB, Goldstein DE.The National Glycohemoglobin Standardization Program (NGSP)- a five-year progress report. Clin Chem 2001;47: 1985-992.
13. Joergensen LGM, Branslund I, Stahl M, Hyltoft Petersen P, Iversen S et.al. Upper reference limit, analytical quality specifications and clinical use of haemoglobin A1c. Scand J Clin Lab Invest 2002; 62: 609-622.
14. Kobold U, Jeppson JO, Dulffer T, Finke A, Hoelzel W, Miedema K. Candidate reference methods for hemoglobin A1c based on peptide mapping. Clin Chem 1997; 43:1944-1951.
15. Weitgasser R, Gappmayer P, Pichler M. Newer portable glucose meters- analytical improvement compared with previous generation devices? Clin Chem 1999; 45:1821-1825.
16. American Diabetes Association. Consensus statement on self--monitoring of blood glucose. Diabetes Care 1987; 10: 93-99.
17. National Committee for Clinical Laboratory Standards.Ancillary (bedside) blood glucose testing in acute and chronic care facilities. Approved guideline C30-A 1994; 14:1-14. NCCLS, Villanova, PA.
18. In vitro diagnostic test systems-Requirements for blood--glucose monitoring systems for self-momitoring in managing diabetes mellitus. ISO/DIS 15197-2. International Organization for Standardization 2002.
19. American Diabetes Association. Diabetes Nephropathy. Diabetes Care 1999; 22 (Suppl 1): S66-S69.
20. Kouri T, Fogazzi G, Gant V, Hallander H, Hofmann W, Guder WG.: European Urinalysis Giudelines. Scand J Clin Lab Invest 2000; vol. 60; Supplement 231 1-96.
21. Poulsen PL, Hansen B, Amby T, Terkelsen T, Mogensen CE. Evaluation of dipstick test for microalbuminuria in three different clinical settings including the correlation with urinary albumin excretion rate. Diabetes Metab 1992; 18: 395-400.
22. Porter WH, Yao HH,Karounos DG. Laboratory and clinical evaluation of assays for β-hydroxybutyrate.Am J Clin Pathol 1997; 107: 353-358.
23. American Diabetes Association. Test of glycemia(Position Statement). Diabetes Care 2000; 23 (Suppl 1): S80-S82.
24. Ko GT,Chan JC,Woo J, Lau E, Yeung VT a spol. The reproducibility and usefulness of the oral glucose tolerance test in screening for diabetes. Ann Clin Biochem 1998; 35: 62-67.
25. Atkinson MA, Eisenbarth GS. Type 1diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001; 358: 21-229.
26. Klein J, Sato A. The HLA system. First of two. A Engl J Med 2000; 343: 702-709.
27. Monitoring glycaemic control in the diabetic patient. Ed. W Garry John IFCC Series. Excerpta Medica Publications, London, 2002